Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection in Scotland. Although the majority of men and women with chlamydial infection are asymptomatic it can cause significant short- and long-term morbidity with accompanying costs to the individual and the health service.
Remit and target users
This guideline covers chlamydial infection of the genital tract and rectum and provides recommendations on: laboratory tests; testing asymptomatic groups at risk of infection; testing for other sexually transmitted infections; antimicrobial treatments; follow up and test of cure; partner notification; primary prevention and prevention of re-infection; and provision of information for patients and partners.
This guideline will be of interest to primary care practitioners, patients, people at risk of infection, charities and voluntary organisations with an interest in sexual health, microbiologists, pharmacists, medical and nursing specialists in sexual health and genitourinary medicine, gynaecologists, sexual health advisers, and public health specialists.
How this guideline was developed
This guideline was developed using a standard methodology based on a systematic review of the evidence. Further details can be found in SIGN 50: A Guideline Developer’s Handbook .
Keeping up to date
This guideline was issued in 2009 and will be considered for review in three years. The review history, and any updates to the guideline in the interim period, will be noted in the review report.
Use with caution, declaration of interests governance may not be in line with current policy.
Full guideline (PDF)
Quick reference guide (PDF)
Register of Interests
Search narrative (PDF)
Costing template (Excel)
Copyright permission (PDF)
Contact us email@example.com
SIGN 109, March 2009
ISBN 978 1 905813 44 5
Register of Interest
A register of interest is not available for this guideline. In line with the SIGN Document Retention Schedule (24/07/2010), after publication of this guideline, hard copies of declarations of interest were held at the SIGN Executive offices for one year. The declarations of interest were then archived for a further three years before being destroyed along with other guideline related documents. This schedule has now been revised.